+ Follow Herceptin Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 912240
[Title] => FDA approves new targeted breast cancer drug
[Summary] => The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
[DatePublished] => 2013-02-23 00:20:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] =>
)
[1] => Array
(
[ArticleID] => 756015
[Title] => Big promise seen in 2 new breast cancer drugs
[Summary] => Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
[DatePublished] => 2011-12-08 11:17:49
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 560018
[Title] => Roche poised for long-term growth
[Summary] => Roche is set to strengthen its global leadership position in oncology and to expand in therapeutic areas such as metabolism, inflammation and diseases of the central nervous system.
[DatePublished] => 2010-03-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[3] => Array
(
[ArticleID] => 531814
[Title] => Novel drug combo improves breast cancer survival
[Summary] => SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, doctors reported Frida
[DatePublished] => 2009-12-13 00:01:11
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[4] => Array
(
[ArticleID] => 531829
[Title] => Novel drug combo ups breast cancer survival
[Summary] => Some women with very advanced breast cancer may have a new treatment option.
[DatePublished] => 2009-12-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
[5] => Array
(
[ArticleID] => 329781
[Title] => Good news about breast cancer
[Summary] => 
There are more reasons than ever to be hopeful after a diagnosis of breast cancer. Despite its prevalence – breast cancer is the most common cancer among women – survival rates have increased. One reason is that advances in mammography have made it possible to detect very small tumors. Smaller tumors are usually easier to treat, less likely to spread to lymph nodes, lungs, or bones, and present a greater chance for breast preservation and cure.
[DatePublished] => 2006-04-04 00:00:00
[ColumnID] => 133436
[Focus] => 0
[AuthorID] => 1778504
[AuthorName] => Tyrone M. Reyes M.D.
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
Herceptin
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 912240
[Title] => FDA approves new targeted breast cancer drug
[Summary] => The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
[DatePublished] => 2013-02-23 00:20:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] =>
)
[1] => Array
(
[ArticleID] => 756015
[Title] => Big promise seen in 2 new breast cancer drugs
[Summary] => Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
[DatePublished] => 2011-12-08 11:17:49
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 560018
[Title] => Roche poised for long-term growth
[Summary] => Roche is set to strengthen its global leadership position in oncology and to expand in therapeutic areas such as metabolism, inflammation and diseases of the central nervous system.
[DatePublished] => 2010-03-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[3] => Array
(
[ArticleID] => 531814
[Title] => Novel drug combo improves breast cancer survival
[Summary] => SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, doctors reported Frida
[DatePublished] => 2009-12-13 00:01:11
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[4] => Array
(
[ArticleID] => 531829
[Title] => Novel drug combo ups breast cancer survival
[Summary] => Some women with very advanced breast cancer may have a new treatment option.
[DatePublished] => 2009-12-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
[5] => Array
(
[ArticleID] => 329781
[Title] => Good news about breast cancer
[Summary] => There are more reasons than ever to be hopeful after a diagnosis of breast cancer. Despite its prevalence – breast cancer is the most common cancer among women – survival rates have increased. One reason is that advances in mammography have made it possible to detect very small tumors. Smaller tumors are usually easier to treat, less likely to spread to lymph nodes, lungs, or bones, and present a greater chance for breast preservation and cure.
[DatePublished] => 2006-04-04 00:00:00
[ColumnID] => 133436
[Focus] => 0
[AuthorID] => 1778504
[AuthorName] => Tyrone M. Reyes M.D.
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
February 23, 2013 - 12:20am
December 8, 2011 - 11:17am
December 13, 2009 - 12:01am
December 13, 2009 - 12:00am
